TORONTO, Sept. 10, 2020 /PRNewswire/ – ACTO, the leading omnichannel education and engagement platform for life sciences, today announced its acquisition of Scrimmage, a pioneering mobile learning provider. Following ACTO’s $11.5M Series A round, the acquisition establishes ACTO as a life sciences SaaS leader with an unparalleled portfolio of 100+ clients, including seven of the top 20 pharma companies and six of the top 20 medical device companies. ACTO will now serve hundreds of thousands of learners in 100+ countries, drawing on a combined workforce of over 100 team members.
Scrimmage unveiled its flagship app in 2010 coinciding with the launch of the first iPad. Over the last decade, its award-winning mobile learning platform has seen over 1 billion platform touchpoints, evolving into a one-stop solution for any device, anywhere. Using gamification, social features, and sophisticated mobile learning strategies, Scrimmage helps life sciences companies to empower learners and drive field performance with accessible, engaging, and integrated people-first tools.